Literature DB >> 22434516

Structural and functional distinctiveness of HLA-A2 allelic variants.

Kenneth Yuanxiang Chen1, Jingxian Liu, Ee Chee Ren.   

Abstract

Human leukocyte antigen (HLA) class I molecules are involved in the presentation of antigenic peptides to CD8(+) cytotoxic T lymphocytes (CTLs), which is important for the development of cellular immunity during viral infections and in cancers. HLA-A2 is one of the most frequent HLA class I specificities and thus is extensively studied structurally and functionally. Since its discovery, more than 300 allelic variants of this HLA specificity have been recorded. Among the HLA-A2 allelic variants, HLA-A*02:01 is the most prevalent, hence commonly used as a model to study HLA-A2-restricted CTL responses. However, HLA-A2 alleles are unevenly distributed globally such that HLA-A2 allelic variants besides A*02:01 are expressed at considerably high frequencies in Asian and African populations. Furthermore, increasing evidence of variations in the peptide-binding repertoire and CTL responses among HLA-A2 allelic variants suggests the need to understand these differences among various frequently expressed HLA-A2 molecules. In this review, the structural and functional distinctiveness of HLA-A2 allelic variants will be discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22434516     DOI: 10.1007/s12026-012-8295-5

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  62 in total

1.  The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization.

Authors:  Lars Kjer-Nielsen; Craig S Clements; Andrew G Brooks; Anthony W Purcell; Marcos R Fontes; James McCluskey; Jamie Rossjohn
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

2.  [Iso-leuko-antibodies].

Authors:  J DAUSSET
Journal:  Acta Haematol       Date:  1958 Jul-Oct       Impact factor: 2.195

Review 3.  More than one reason to rethink the use of peptides in vaccine design.

Authors:  Anthony W Purcell; James McCluskey; Jamie Rossjohn
Journal:  Nat Rev Drug Discov       Date:  2007-05       Impact factor: 84.694

4.  Association of vitiligo with HLA-A2: a meta-analysis.

Authors:  J-B Liu; M Li; H Chen; S-Q Zhong; S Yang; W-D Du; J-H Hao; T-S Zhang; X-J Zhang; M P Zeegers
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-02       Impact factor: 6.166

5.  Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity.

Authors:  M Matsui; R J Moots; A J McMichael; J A Frelinger
Journal:  Hum Immunol       Date:  1994-10       Impact factor: 2.850

Review 6.  Major histocompatibility complex and sporadic Alzheimer's disease: a critical reappraisal.

Authors:  Giuseppina Candore; Carmela Rita Balistreri; Giuseppina Colonna-Romano; Domenico Lio; Calogero Caruso
Journal:  Exp Gerontol       Date:  2004-04       Impact factor: 4.032

7.  Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire.

Authors:  Anthony Tanoto Tan; Elisabetta Loggi; Carolina Boni; Adeline Chia; Adam J Gehring; Konduru S R Sastry; Vera Goh; Paola Fisicaro; Pietro Andreone; Christian Brander; Seng Gee Lim; Carlo Ferrari; Florian Bihl; Antonio Bertoletti
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

8.  Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan.

Authors:  Kelly J Yu; Xiaojiang Gao; Chien-Jen Chen; Xiaohong Rose Yang; Scott R Diehl; Alisa Goldstein; Wan-Lun Hsu; Xueying Sharon Liang; Darlene Marti; Mei-Ying Liu; Jen-Yang Chen; Mary Carrington; Allan Hildesheim
Journal:  Hum Immunol       Date:  2009-08-13       Impact factor: 2.850

9.  HLA class I supertypes: a revised and updated classification.

Authors:  John Sidney; Bjoern Peters; Nicole Frahm; Christian Brander; Alessandro Sette
Journal:  BMC Immunol       Date:  2008-01-22       Impact factor: 3.615

10.  HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.

Authors:  Boel Brynedal; Kristina Duvefelt; Gudrun Jonasdottir; Izaura M Roos; Eva Akesson; Juni Palmgren; Jan Hillert
Journal:  PLoS One       Date:  2007-07-25       Impact factor: 3.240

View more
  14 in total

1.  How structural adaptability exists alongside HLA-A2 bias in the human αβ TCR repertoire.

Authors:  Sydney J Blevins; Brian G Pierce; Nishant K Singh; Timothy P Riley; Yuan Wang; Timothy T Spear; Michael I Nishimura; Zhiping Weng; Brian M Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

2.  Full screening and accurate subtyping of HLA-A*02 alleles through group-specific amplification and mono-allelic sequencing.

Authors:  Shengli Song; Miaomiao Han; Han Zhang; Yuanxia Wang; Hong Jiang
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

Review 3.  Maternal microchimerism in biliary atresia: are maternal cells effector cells, targets, or just bystanders?

Authors:  Toshihiro Muraji
Journal:  Chimerism       Date:  2014-03-26

4.  Modeling Sequence-Dependent Peptide Fluctuations in Immunologic Recognition.

Authors:  Cory M Ayres; Timothy P Riley; Steven A Corcelli; Brian M Baker
Journal:  J Chem Inf Model       Date:  2017-07-25       Impact factor: 4.956

5.  POTN: A Human Leukocyte Antigen-A2 Immunogenic Peptides Screening Model and Its Applications in Tumor Antigens Prediction.

Authors:  Qingqing Meng; Yahong Wu; Xinghua Sui; Jingjie Meng; Tingting Wang; Yan Lin; Zhiwei Wang; Xiuman Zhou; Yuanming Qi; Jiangfeng Du; Yanfeng Gao
Journal:  Front Immunol       Date:  2020-10-07       Impact factor: 7.561

6.  Associations of HLA class I alleles in Japanese patients with Crohn's disease.

Authors:  D Oryoji; T Hisamatsu; K Tsuchiya; J Umeno; S Ueda; K Yamamoto; T Matsumoto; M Watanabe; T Hibi; T Sasazuki
Journal:  Genes Immun       Date:  2014-11-06       Impact factor: 2.676

7.  Induction of an antitumor response using dendritic cells transfected with DNA constructs encoding the HLA-A*02:01-restricted epitopes of tumor-associated antigens in culture of mononuclear cells of breast cancer patients.

Authors:  Sergey Vital'evich Sennikov; Julia Alexandrovna Shevchenko; Vasilii Vasil'evich Kurilin; Julia Nikolaevna Khantakova; Julia Anatol'evna Lopatnikova; Elena Vasil'evna Gavrilova; Rinat Amirovich Maksyutov; Anastasiya Yur'evna Bakulina; Sergey Vasil'evich Sidorov; Alexander Alexandrovich Khristin; Amir Zakievich Maksyutov
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

8.  Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican‑3‑derived peptide.

Authors:  Yoshitaka Tada; Toshiaki Yoshikawa; Manami Shimomura; Yu Sawada; Mayuko Sakai; Hirofumi Shirakawa; Daisuke Nobuoka; Tetsuya Nakatsura
Journal:  Int J Oncol       Date:  2013-07-31       Impact factor: 5.650

9.  Human malignant melanoma-derived progestagen-associated endometrial protein immunosuppresses T lymphocytes in vitro.

Authors:  Suping Ren; Lina Chai; Chunyan Wang; Changlan Li; Qiquan Ren; Lihua Yang; Fumei Wang; Zhixin Qiao; Weijing Li; Min He; Adam I Riker; Ying Han; Qun Yu
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

10.  Immunogenicity of Multi-Epitope DNA and Peptide Vaccine Candidates Based on Core, E2, NS3 and NS5B HCV Epitopes in BALB/c Mice.

Authors:  Leila Pishraft Sabet; Tahereh Taheri; Arash Memarnejadian; Talat Mokhtari Azad; Fatemeh Asgari; Ramin Rahimnia; Seyed Moayed Alavian; Sima Rafati; Katayoun Samimi Rad
Journal:  Hepat Mon       Date:  2014-10-15       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.